![]() ![]() Identified, on a case-by-case basis, from scientific evidence as causing probable serious effects to human health or the environment of an equivalent level of concern as those above (e.g. ![]() ![]() ![]() Persistent, Bioaccumulative and Toxic (PBT) or very Persistent and very Bioaccumulative (vPvB) according to the criteria in Annex XIII of the REACH Regulation, orģ. Carcinogenic, Mutagenic or toxic to Reproduction (CMR), meeting the criteria for classification in category 1 or 2 in accordance with Directive 67/548/EEC or in category 1a or 1b in accordance with EC No 1272/2008This directive was recently replaced by the new EU regulation (EC) No 1272/2008.Ģ. SVHC are defined in Article 57 of Regulation (EC) No 1907/2006 (“the REACH Regulation”) and include substances which are:ġ. Project will be the first commercial installation for the Company in North America and will serve as a reference site for securing larger sales in the territoryĨ June 2022: Smart building materials company ClearVue Technologies Limited (ASX:CPV OTC:CVUEF) (“ ClearVue” or the “ Company”) announces that it has signed a letter of intent ( LOI) to install its patented solar energy windows at into a new office building in Atlanta, Georgia – the first such commercial installation in North America by the Company.Project will use 250 square metres of ClearVue photovoltaic glazing.LOI with LabReal LLC calls for installation at new medical office and laboratory building in Atlanta, Georgia.SVHC is a substance (identified by the European Chemicals Agency) that may have serious and often irreversible effects on human health and the environment. The LOI has been signed with LabReal LLC for installation of 250 square meters (2691 square feet) into at a new medical office and laboratory building located on Clairmont Road in Atlanta. Pimsler Hoss Architecture ( ), based in Atlanta, is the architect for the building project. LabReal LLC is a private investment company based in Atlanta, Georgia. The Project is in final planning stages with construction expected to start during the fourth quarter of 2022.ĬlearVue has so far deployed its solar glass in various projects in Asia-Pacific including a greenhouse in Japan as well as conducting a trial in a building in New York exploring the energy efficiency and power performance aspects of the ClearVue product.īasil Karampelas, North American CEO for ClearVue said: LabReal has contracted with a confidential client which will lease the new purpose-built medical offices, lab and diagnostic services building. “ClearVue is the only company in the world that has a clear solar-glass product deployed and installed in the market. The Atlanta project is but the first in the U.S., a market we believe will be very accepting of our technology.”Įxecutive Chairman Victor Rosenberg added: ClearVue’s electricity generating clear glazing technology is strategically positioned to complement and support the case for the increased use of energy-efficient windows now being regulated in response to global climate change and energy efficiency and carbon footprint reduction goals. “The ClearVue technology represents a paradigm shift in the way glass will be used in building construction. The Atlanta project will demonstrate this and provide a key reference site for the company in this target territory.” Glass will no longer be just a component of construction, but also a renewable energy source and a key element in construction decarbonization efforts- both for refurbishments and for new builds. “We are delighted to be at the forefront of installing ClearVue’s extraordinary window technology. We take energy efficiency and sustainability very seriously and the ClearVue windows will advance our clean energy goals.”Įarlier this month, ClearVue announced that together with Nodis ( it will participate in a US. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |